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Objectives: The current study aims at assessing the effectiveness of the guidelines set up by our clinic for the
protection of patients and staff which enabled us to proceed with urgent and oncological surgery after the
outbreak of the Covid-19 pandemic.
Material and methods: Our ENT department devised specific equipment to be worn by the staff for personal
protection when dealing with Covid-19 patients both in aerosol generating and non-generating procedures.
Moreover, restrictive measures were enforced both for the outpatient department and for the ward where only
urgent practices were carried out and visitors were not allowed, while non-urgent elective surgery was post-
poned. A codified scheme was followed to perform tracheostomy procedure in Covid-19 positive testing patients
on the part of 3 specific teams of 2 surgeons each, while the resident educational program was reorganized to
limit the spread of the infection.
Results: In about a couple of months (from March 8th to May 3rd) a relevant amount of medical tests and
surgical procedures were carried out on non COVID-19 patients and a certain number of tracheostomies were
performed on COVID-19 patients. Consequently, all the ENT personnel were checked and found negative. Also,
all the patients in the ward were swab tested and chest X-rayed, only one had a positive outcome and was
adequately handled and treated.
Conclusion: Our ENT guidelines regarding personal protection equipment and multiple simultaneous diagnostic
procedures have proved to be an essential instrument for the management of patients with both known and
unknown COVID-19 status.
1. Introduction
In Italy there have been so far (June 6th, 2020) more than 234.000
cases of COVID-19 positive testing patients of which about 33,800 have
deceased, most of whom were elderly people (mean age 80) with pre-
existing illnesses.
Everything started on January 30th when two Chinese tourists
coming from Wuhan were hospitalized at Spallanzani Hospital in Rome
displaying symptoms compatible with COVID-19 disease (high tem-
perature, cough, breathing difficulty).
The first case of secondary transmission occurred on February 18th
in Codogno in Lombardy which became the district with the highest
percentage of cases.
A vast surveillance and screening network was immediately set up
and a panel of experts was called to define procedures.
On February 23rd some areas, where the infection was most wide-
spread, were restricted access and in March all commercial businesses
as well as all non-essential manufacturing activities were shut down.
Lockdown was enforced and people were told to stay at home, save for
vital necessities, and to work from home where possible and, with few
exceptions (work, health problems and urgencies), they couldn't move
from their hometown.
Italy was one of the first countries to be affected by the SARS-CoV-2
pandemic, and one of the worst-hit in Europe.
For this reason, the Italian health system had to handle an un-
expected number of hospitalized patients in its wards and intubated
patients in the Intensive Care Units.
This implied the reorganization of entire hospitals and great
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changes in the working practices [1].
There was no time to test and verify both plans and protocols as
ENTs also faced the pandemic by preparing new admission/pre-
operative guidelines within a short time.
COVID-19 does not affect only elderly people since, according to a
European epidemiological study, the mean age of the people suffering
from COVID-19 was 39.17 ± 12.09 years [2].
As this infectious disease affects all ages and every kind of patient,
including ENT ones, we had to change our daily practice in order to
create adequate protocols also for the ENT staff protection.
In the Veneto area the first COVID-19 case was diagnosed on
February 27th, and the pandemic peak occurred around April 1st with
350 new critical patients in ICU and 1718 new non-critical patients in
the wards. To June 6th in Veneto we had a total of 19,183 COVID-19
patients, of which 5558 were hospitalized and 1954 died [3].
In the whole Italian country, a considerable percentage (20%) of
COVID-19 cases were healthcare workers, and some of them died [4].
There were no pre-existing protocols or guidelines, therefore we
elaborated a protocol to try to keep a “COVID-19 free” clinic and ward,
managing our resources in view of a possible shortage of personal
protection equipment in the first stage of the pandemic in Italy.
The current study aims at assessing the effectiveness of the mea-
sures/guidelines followed in our Clinic, to continue our urgent and
oncological surgical activity, while preserving a “COVID-19 free” en-
vironment and protecting our patients and staff. This was important to
limit the spread of the infection.
2. Material and methods
2.1. Staff
Our protocol devised access restriction of patients and medical staff.
Our ENT medical staff in Verona is composed of:
15 ENT specialists;
17 residents.
Throughout the SARS-CoV-2 pandemic, our surgical and clinical
activities decreased and the resident educational program was sig-
nificantly altered, in fact ENT residents had 2 weeks of internship and
work alternating with 2 weeks of lockdown, for their protection.
Every day 2 medical doctors worked both in the ward and in the
clinic, while 3 of them were involved in surgery.
2.2. Patients
As far as the different branches of our ENT clinic are concerned, in
the outpatient department we carried out urgent medical examinations
or the ones which required investigation within 10 days, in particular
post-hospitalization non deferrable medications and cancer patients'
evaluation. All the other non-urgent visits were postponed. In any case
all the patients accessing the outpatient department were strictly re-
quired to wear a facial mask.
Restrictive measures were introduced for our ward as well. Only
urgent patients (like the ones with neck abscesses and dyspnoea) were
admitted to the ward, as well as cancer patients who needed to undergo
surgery. No visitors were allowed, save special cases like the assistance
of patients with dementia or underage ones, in which only one visitor
was admitted.
Patients pending hospital admission who suffered from high tem-
perature, dyspnoea and rhinorrhoea had to contact the on-call physi-
cian on the phone and they couldn't gain access to the ward.
For what concerns the operating room it was used for head and neck
cancer surgery, for emergency procedures such as the drainage of neck
abscesses, urgent tracheostomies, bleeding control and the management
of post-surgical complications. Non-urgent elective surgery was
postponed.
2.3. Patients with surgical indication
Every patient who needed surgery was admitted and isolated in an
appropriate triage room, apart from the ward, in order to keep a
“COVID-19 free” ward.
All the hospitalized patients were tested for SARS-CoV-2 infection
with RT-PCR from a swab of the oropharyngeal, nasopharyngeal mu-
cosa and of both nasal cavities in search of SARS-CoV-2 and pulse
oximetry was measured. Until they got their results they were isolated
in a single room and they had to wear a surgical mask. If they tested
negative, they would undergo chest X-rays and walking test, to exclude
SARS-CoV-2 infection.
In case of negative swab test, the patients could be moved from the
triage room to the ward to undergo surgery the following day.
On the other hand, in case of a positive swab or if the swab was
negative but chest X-rays were doubtful or walking test was suggestive
of SARS-CoV-2 infection, surgery was postponed, and the patient was
isolated at home and followed by his general practitioner, until he had 2
negative swab tests in a row. None of this was taken into account for
emergency surgery.
2.4. Tracheostomy procedure in COVID patients
During the pandemic, part of the surgical activity was necessarily
represented by tracheostomies in COVID-19 patients. Our protocol re-
quired the performance of these procedures in the COVID-19 dedicated
area at the patient's bed.
Moreover, we set up 3 teams, made up of 2 surgeons each, to per-
form tracheostomy procedures for COVID-19 positive testing patients.
These teams operated in both hospitals of our city 3 times a week, so
that each group was involved in surgery (2 daily tracheostomies at
most) just once a week. This schedule allowed minimum exposure to
the virus of the team's members. This procedure followed some precise
surgical steps. First of all, the trachea was exposed, then the ventilation
tube was positioned in the most caudal portion of the trachea. Then, the
trachea was incised and connected to the skin. Subsequently the apnoea
state was reinstated and the endotracheal tube was replaced with a
tracheostomy cannula, the circuit was eventually connected with a
closed circuit and ventilation restarted.
2.5. Use of personal protection equipment
The reduced working time of medical staff was important for their
safety and to avoid protection equipment waste.
Protection equipment was used only by the medical staff according
to the risk of infection in our clinic, in the operating room and in the
dressing room of the ward.
According to the below mentioned settings the protocol required the
protections mentioned below.
2.5.1. Operating room
In particular, when dealing with COVID-19 negative swab testing
patients, while performing procedures which did not generate aerosol,
our medical staff was instructed to wear both a FFP2 and a surgical
mask, a disposable gown, one pair of gloves, eye and face protection
devices and shoe covers. For the procedures which generated aerosol in
COVID-19 negative testing patients, the medical staff wore a FFP2 and a
surgical mask, one disposable gown and a sterile disposable gown
above it, two pairs of gloves plus a sterile one, eye and face protection
devices, a cap, a surgical drape around the neck and two shoe covers.
Conversely, while dealing with COVID-19 positive testing patients,
for both aerosol generating and non-generating procedures, the medical
staff wore an FFP3 and a surgical facial mask, one disposable gown plus
a sterile gown above it, two gloves plus another sterile one, eye and face
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protection, two caps, a surgical drape around the neck and two shoe
covers.
2.6. Clinic
Patients who accessed the clinic had to wear a surgical mask and
gloves. For otological examinations, the staff wore a surgical mask, and
gloves, since no aerosol production was involved. Instead, for oncolo-
gical visits, pharynx and larynx evaluations, the medical staff wore an
FFP2 mask, a surgical mask, face protection, a disposable gown, gloves
and a cap (for risky aerosol producing procedures).
2.6.1. Ward (dressing room)
The medical staff wore an FFP2 mask, a surgical mask, a face pro-
tection device, a gown, gloves and a cap for dressings procedures, to
clean and change tracheostomy tubes, inner cannula, etc. in the ward.
3. Results
All the protocols described in Section 2. Material and methods were
enforced for all ENT activities from March 8th to May 3rd (phase 1).
3.1. Restrictive protocol
During phase 1, all ENT staff members (both residents and specia-
lists) did not show any COVID-19 related symptoms. At the end of
March, the whole staff was tested for the search of SARS-CoV-2 RNA
through nasopharyngeal and oropharyngeal mucosa swab test and they
all tested negative. Even though the whole wore adequate personal
protection equipment the swab test was repeated for those involved in
aerosol-producing procedures with COVID-19 positive patients (such as
endotracheal tube cuff rupture during a tracheostomy procedure) and
they all tested negative again.
3.2. Patients with surgical indication
During this time, we performed:
216 medical examinations in the Emergency Department;
1264 outpatient check-ups and hospitalized patients consulting;
80 surgical procedures in patients with negative COVID-19 tests.
We performed 13 tracheostomies, 4 lateral skull base procedures, 3
anterior skull base procedures, 43 oncologic head and neck surgeries,
17 other procedures.
All hospitalized patients were tested with a nasopharyngeal and
oropharyngeal mucosa swab in search of SARS-CoV-2 RNA and subse-
quently chest X-rayed.
Out of 80 hospitalized patients, 1 patient without any symptoms
tested positive for COVID-19 during swab testing. She was isolated in
the triage room until the test results came, then she was immediately
discharged wearing gloves and a surgical mask, isolated at home and
followed by her general practitioner.
None of the patients who had a negative swab test, showed any sign
suggestive of COVID-19 when chest X-rayed or when undergoing
walking test. Patients who showed symptoms compatible with COVID-
19 during hospitalization (cough, fever, rhinorrhea), repeated the swab
test, and none of them tested positive.
3.3. Tracheostomy procedure in COVID-19 patients
The three above-mentioned équipes performed 22 tracheostomies
on COVID-19 patients altogether, every team was involved in surgery
once a week, with an average of 6 tracheostomies each team. None of
the surgeons got a positive swab when tested, nor any COVID-19 related
symptoms.
4. Discussion
The epidemic of COVID-19 caught the Italian Health Care Service
unprepared, therefore it was necessary to set up protocols and re-
organize hospitals for COVID-19 and non-COVID-19 patients.
The protocol implemented in our ENT Clinic represents one of the
first ENT ones during the pandemic, after the Chinese experience.
Assessment of this protocol was made after it was confirmed that the
great majority of people suffering from COVID-19 disease (50–75%) did
not show any symptoms but represented “a formidable source” of in-
fection [5] and that the performed oropharynx and nasopharynx mu-
cosa swab tests led to a high percentage of false negatives.
Among the available tests (serological, swab) to detect SARS-CoV-2,
we decided to use the swab test because it is easy and user-friendly even
though, despite being widely used, it shows a high percentage of false
negatives.
A Chinese study dating back to February 2020, showed that reverse
transcription polymerase chain reaction (RT-PCR) test results of phar-
yngeal swab specimens were variable and potentially unstable. So, we
realized that swab testing should not be considered as the only possible
indicator of diagnosis, treatment, isolation, recovery/discharge and
relocation for hospitalized patients clinically diagnosed with COVID-19
[6].
Indeed, several factors have been proposed to explain the incon-
sistency or the high false negative rate [7].
For example, results from RT-qPCR testing using primers in the
ORF1ab gene and N genes can be influenced by the variation of viral
RNA sequences. In terms of natural history of the disease and viral load
in different anatomic sites of the patients, sampling procedures largely
contribute to a high number of false negative results. According to es-
timates, false negative results from one-time testing were as high as
30–50% in real COVID-19 cases [8].
False negatives may also be caused by insufficient viral material in
the specimen, laboratory errors during sampling, or inconveniences in
sample transportation [9].
Another study found that the positive rate of 2019-nCoV nucleic
acid test of sputum is more accurate if compared to the nasopharyngeal
mucosa. It also concluded that multi-sample 2019-nCoV nucleic acid
detection can improve the accuracy and reduce the false negative rate
[10].
Since in patients with acute influenza, nasopharyngeal swabbing
was clearly superior to oropharyngeal one in terms of diagnostic yield
through real-time PCR, we preferred to test both oropharyngeal and
nasopharyngeal mucosa [11].
Therefore, we decided to perform a mucosa swab RT-PCR test (both
nasopharyngeal and oropharynx mucosa) on every patient pending
hospitalization, combined with chest X-rays and pulse oximetry.
Through the execution of the combination of these 3 tests, diagnosis
of COVID-19 became more accurate.
In our Italian experience with COVID-19 patients we noticed a clear
disproportion between the degree of dyspnoeic symptoms and the
pulmonary status. Some of the COVID-19 patients did not show any
apparent symptoms but their chest X-rays showed interstitial pneu-
monia, or desaturation during the walking test, suggesting a SARS-CoV-
2 infection.
Hence, the importance of combining more diagnostic tests to in-
crease validity from experience and literature reviews. Therefore, we
noticed that the combination of swab testing, chest X-rays and pulse
oximetry leads to a more adequate screening by reducing the numbers
of false negative results.
The major mode of human-human transmission of SARS-CoV-2 is
presumed to be through respiratory droplets, even if evidence suggests
that the virus may also spread via the faecal-oral route and through the
conjunctiva [12].
Early reports also suggest the possibility of transmission during
aerosol-generating procedures, like instrument usage in the upper
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aerodigestive tract.
For this reason and because the viral load of SARS-CoV-2 is higher
in the nasal cavity than in the pharynx [13], upper airway examination
and procedures, as well as endoscopic or open sinus and skull base
surgery should be considered extremely risky operations for the trans-
mission of SARS-CoV-2 [14].
ENT is one of the branches with the highest risk of SARS-CoV-2
contagion, as it requires the management of the upper airways [15].
Since in case of ENT emergency surgery or in outpatient ENT ex-
aminations, the patient has an unknown COVID-19 status (testing being
impossible), healthcare workers must wear protective equipment and
follow the same procedures as they would, in case of COVID-19 positive
patients. Conversely, when oncologic surgery is performed, there is the
possibility to test the patient through lab tests, swab tests, pulse oxi-
metry and chest X-rays. Therefore, knowing the COVID-19 state of the
patient, the staff will decide the appropriate protective equipment.
Since our protocol was used during phase 1, we did not observe any
infected healthcare workers. None of the members of the whole staff
was infected or presented COVID-related symptoms.
Regarding tracheostomy, the timing in the critically ill COVID-19
positive patient is a controversial issue. Siempos et al. found no sig-
nificant difference in the mortality outcome between early (< 48 h)
and late (> 15 days) tracheostomy [16].
In literature, open tracheostomy is considered superior to the per-
cutaneous procedure for a number of reasons. First, it shows a pre-
sumed lower risk of producing viral droplets or aerosols [17], secondly
there is no need of a simultaneous bronchoscopy, last but not least it
does not require a long period of exposure to an open tracheostomy site
during serial dilations resulting in an increased risk of virus aero-
solization [18].
In our Clinic the staff specifically devoted to performing tracheos-
tomies in COVID-19 positive patients tested negative throughout and
they did not show any symptoms. Following our protocol, the tra-
cheostomy procedure did not involve the production of aerosol or it was
minimized.
In our COVID Units, a trained observer checked personal protective
equipment doffing, to minimize self-contamination after high risk
procedures, which was consistent with Chinese recommendations
[19,20].
5. Conclusion
To face the SARS-CoV-2 pandemic it is paramount for the ENT staff
to have adequate personal protective equipment, a proper protocol to
be followed for the management of known, dubious or positive COVID-
19 patients and suitable guidelines for both the staff and the patients'
safety.
References
[1] Mannelli G, et al. Impact of COVID-19 pandemic on Italian otolaryngology units: a
nationwide study. Acta Otorhinolaryngol Ital 2020. May. In press.
[2] Lechien JR, et al. Clinical and epidemiological characteristics of 1,420 European
patients with mild-to-moderate coronavirus disease 2019. J Intern Med Apr. 2020.
https://doi.org/10.1111/joim.13089. p. joim.13089.
[3] Emergenza Coronavirus SARS-CoV-2/COVID-19. https://www.azero.veneto.it/-/
emergenza-coronavirus; 06/06/2020.
[4] Remuzzi A, Remuzzi G. COVID-19 and Italy: what next? Lancet
2020;395(10231):1225–8. Apr https://doi.org/10.1016/S0140-6736(20)30627-9.
[5] Day M. Covid-19: identifying and isolating asymptomatic people helped eliminate
virus in Italian village. BMJ 2020:m1165. Mar https://doi.org/10.1136/bmj.
m1165.
[6] Li Y, et al. Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients
clinically diagnosed with COVID-19. J Med Virol 2020. https://doi.org/10.1002/
jmv.25786. Apr.
[7] Rainer TH. The spectrum of severe acute respiratory syndrome–associated cor-
onavirus infection. Ann Intern Med 2004;140(8):614. Apr https://doi.org/10.7326/
0003-4819-140-8-200404200-00008.
[8] Wang Y, Kang H, Liu X, Tong Z. Combination of RT-qPCR testing and clinical fea-
tures for diagnosis of COVID-19 facilitates management of SARS-CoV-2 outbreak. J
Med Virol 2020;92(6):538–9. Jun https://doi.org/10.1002/jmv.25721.
[9] Qian M, Yi Q, Qihua F, Ming G. Understanding the influencing factors of nucleic
acid detection of 2019 novel coronavirus. Chin J Lab Med Feb. 2020. https://doi.
org/10.3760/cma.j.issn.1009-8158.2020.0002.
[10] Wu J, et al. Detection and analysis of nucleic acid in various biological samples of
COVID-19 patients. Travel Med Infect Dis 2020:101673. Apr. In press https://doi.
org/10.1016/j.tmaid.2020.101673.
[11] Hernes SS, Quarsten H, Hamre R, Hagen E, Bjorvatn B, Bakke PS. A comparison of
nasopharyngeal and oropharyngeal swabbing for the detection of influenza virus by
real-time PCR. Eur J Clin Microbiol Infect Dis 2013;32(3):381–5. Mar https://doi.
org/10.1007/s10096-012-1753-0.
[12] van Doremalen N, et al. Aerosol and surface stability of SARS-CoV-2 as compared
with SARS-CoV-1. N Engl J Med 2020;382(16):1564–7. Apr https://doi.org/10.
1056/NEJMc2004973.
[13] Zou L, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected pa-
tients. N Engl J Med 2020;382(12):1177–9. Mar https://doi.org/10.1056/
NEJMc2001737.
[14] Patel ZM, et al. Letter: precautions for endoscopic transnasal skull base surgery
during the COVID-19 pandemic. Neurosurgery Apr. 2020:nyaa125. https://doi.org/
10.1093/neuros/nyaa125.
[15] Shiba T, Ghazizadeh S, Chhetri D, St. John M, Long J. Tracheostomy considerations
during the COVID-19 pandemic. OTO Open 2020;4(2):2473974X2092252. Jan
https://doi.org/10.1177/2473974X20922528.
[16] Siempos II, Ntaidou TK, Filippidis FT, Choi AMK. Effect of early versus late or no
tracheostomy on mortality and pneumonia of critically ill patients receiving me-
chanical ventilation: a systematic review and meta-analysis. Lancet Respir Med
2015;3(2):150–8. Feb https://doi.org/10.1016/S2213-2600(15)00007-7.
[17] Liu Z, Zhang L. At the center of the COVID-19 pandemic: lessons learned for oto-
laryngology-head and neck surgery in China. Int Forum Allergy Rhinol 2020.
https://doi.org/10.1002/alr.22585. Apr.
[18] Bann DV, et al. Impact of coronavirus (COVID-19) on otolaryngologic surgery: brief
commentary. Head Neck Apr. 2020:hed.26162. https://doi.org/10.1002/hed.
26162.
[19] Zuo M, et al. Expert recommendations for tracheal intubation in critically ill pa-
tients with noval coronavirus disease 2019. cmsj 2020;0(0):0. https://doi.org/10.
24920/003724.
[20] Vukkadala N, Qian ZJ, Holsinger FC, Patel ZM, Rosenthal E. COVID-19 and the
otolaryngologist: preliminary evidence-based review. Laryngoscope Apr.
2020:lary.28672. https://doi.org/10.1002/lary.28672.
D. Marchioni, et al. Am J Otolaryngol 41 (2020) 102676
4
